AU5852000A - Atopy gene - Google Patents

Atopy gene

Info

Publication number
AU5852000A
AU5852000A AU58520/00A AU5852000A AU5852000A AU 5852000 A AU5852000 A AU 5852000A AU 58520/00 A AU58520/00 A AU 58520/00A AU 5852000 A AU5852000 A AU 5852000A AU 5852000 A AU5852000 A AU 5852000A
Authority
AU
Australia
Prior art keywords
atopy
gene
atopy gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58520/00A
Inventor
Chaker Nadim Adra
Julian Meurglyn Hopkin
Taro Shirakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Publication of AU5852000A publication Critical patent/AU5852000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
AU58520/00A 1999-07-09 2000-07-10 Atopy gene Abandoned AU5852000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/196517 1999-07-09
JP19651799A JP2003180356A (en) 1999-07-09 1999-07-09 Atopy gene
PCT/JP2000/004599 WO2001004302A1 (en) 1999-07-09 2000-07-10 Atopy gene

Publications (1)

Publication Number Publication Date
AU5852000A true AU5852000A (en) 2001-01-30

Family

ID=16359067

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58520/00A Abandoned AU5852000A (en) 1999-07-09 2000-07-10 Atopy gene

Country Status (3)

Country Link
JP (1) JP2003180356A (en)
AU (1) AU5852000A (en)
WO (1) WO2001004302A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016783A1 (en) * 2002-08-06 2004-02-26 Genox Research, Inc. Method of examining atopic dermatitis
NZ554824A (en) 2004-10-22 2010-10-29 Revivicor Inc Porcines that lack endogenous antibody chains and express exogenous immunoglobulins
EP2348827B1 (en) 2008-10-27 2015-07-01 Revivicor, Inc. Immunocompromised ungulates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597719A (en) * 1994-07-14 1997-01-28 Onyx Pharmaceuticals, Inc. Interaction of RAF-1 and 14-3-3 proteins
DE69738157T2 (en) * 1996-10-01 2008-05-08 Bio-Rad Laboratories, Inc., Hercules POLYMORPHISM AND NEW GENES IN THE REGION OF HUMAN HEMOCHROMATOSIS

Also Published As

Publication number Publication date
WO2001004302A1 (en) 2001-01-18
JP2003180356A (en) 2003-07-02

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU1878601A (en) Enzyme
AU2001272482A1 (en) Osteolevin gene polymorphisms
AUPQ262599A0 (en) Gene expression
AU4115400A (en) Short-circuiter
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
HUP0105208A3 (en) Gene therapy-1
AU2001264247A1 (en) GASC1 gene
IL146332A0 (en) PrP-LIKE GENE
AU2376200A (en) Insulin-synthesis genes
AU2732000A (en) Reverse gene therapy
AU4916900A (en) Benzofuranylsulfonates
AU6859500A (en) Plant gene
AU4561600A (en) Benzofuranylaminoalcohols
AU2001285743A1 (en) Adipose-related gene
AU5852000A (en) Atopy gene
AU6871900A (en) Tsg-like gene
AU1870000A (en) Gene therapy-2
AU1901801A (en) Glucofuranoses
AU4367900A (en) Carbohydrate-modifying enzymes
AU4435300A (en) Hula-hoop
AU1915601A (en) Periotome
AU2582200A (en) Windturbine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase